Literature DB >> 21484109

Vertical transmission of hepatitis C virus in low to middle socio-economic pregnant population of Karachi.

Sina Aziz1, Nazli Hossain, Saadiya Aziz Karim, Jamila Rajper, Nargis Soomro, Wajeeha Noorulain, Rana Qamar, Rafiq Khanani.   

Abstract

PURPOSE: To determine the rate of vertical transmission (transmission from mother to child) of hepatitis C virus in low to middle socio-economic pregnant women.
METHODS: This study was conducted at Sarwar Zuberi Liver Centre (SZLC) in collaboration with the department of Gynaecology and Obstetrics, Civil Hospital Karachi (CHK) and Abbasi Shaheed Hospital (ASH) for a period of 4 years from September 2005 to December 2009. Total 18,000 women seeking antenatal care were screened for hepatitis C antibodies (Anti-HCV) using 4th generation ELISA technique. Positive 1,043 women were further offered HCV ribonucleic acid (RNA) by polymerase chain reaction (PCR). Six hundred and forty women agreed to have PCR done, and 510 PCR positive women were finally included in the study, followed till delivery and treated if required. Newborns of 510 PCR positive mothers were advised HCV-RNA by PCR from 3 to 12 months of age and Anti-HCV at 18 up to 24 months and followed up to 3 years.
RESULTS: 1,043/18,000 (5.79%) mothers were Anti-HCV positive, of which PCR results of 640 mothers are available where 510/640 (79.7%) were PCR positive, 357/510 (70%) delivered by spontaneous vaginal delivery (SVD), 33 (6.4%) by forceps delivery, 70 (13.7%) had elective, and 50 (9.8%) had emergency caesarian section. Premature rupture of membranes (PROM) was present in 81 mothers. Data of 510 babies from 3 months to 3 years of age was available of which only 215 had their laboratory tests done (HCV-RNA-PCR in 86 and Anti-HCV in 129). Mean birth weight (kg), height (cm) and OFC (cm) were 2.74 ± 0.43, 52.4 ± 7.5, and 35 ± 4. Apgar score median at 1 and 5 min was 7 (range 2-10), 8 (range 4-10), respectively. Low birth weight was present in 49 (9.6%), 37 (7.2%) had history of Neonatal Intensive Care Unit (NICU) admission. PCR of none of the 86 babies done at 3-12 months was positive. Five babies out of 129 were Anti-HCV positive at 18 months of age. Of this, 3/5 was HCV-RNA-PCR positive. Rate of vertical transmission of HCV was 1.39.
CONCLUSION: In spite of the high hepatitis C positivity in pregnant population, the rate of vertical transmission to the neonate is low.

Entities:  

Year:  2010        PMID: 21484109      PMCID: PMC3090561          DOI: 10.1007/s12072-010-9229-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  19 in total

Review 1.  Mother-to-infant transmission of hepatitis C virus.

Authors:  L T Yeung; S M King; E A Roberts
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

2.  Review of antenatal testing policies and practice for HIV and hepatitis C infection.

Authors:  Jenean D Spencer; Diane Tibbits; Christine Tippet; Catherine Mead; John M Kaldor; Gregory J Dore
Journal:  Aust N Z J Public Health       Date:  2003-12       Impact factor: 2.939

3.  Seroprevalence of hepatitis C virus infection and its risk factors in pregnant women.

Authors:  N Khokhar; K S Raja; S Javaid
Journal:  J Pak Med Assoc       Date:  2004-03       Impact factor: 0.781

Review 4.  Hepatitis C and pregnancy.

Authors:  James Airoldi; Vincenzo Berghella
Journal:  Obstet Gynecol Surv       Date:  2006-10       Impact factor: 2.347

5.  Vertical transmission of the hepatitis C virus: Current knowledge and issues.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

6.  Frequency of hepatitis C in pregnancy and pregnancy outcome.

Authors:  Tara Jaffery; Nabia Tariq; Rukhsana Ayub; Ali Yawar
Journal:  J Coll Physicians Surg Pak       Date:  2005-11       Impact factor: 0.711

Review 7.  Epidemiology of hepatitis C in the East.

Authors:  C J Mansell; S A Locarnini
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

8.  Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers.

Authors:  Kirsty England; Lucy Pembrey; Pier-Angelo Tovo; Marie-Louise Newell
Journal:  Acta Paediatr       Date:  2005-04       Impact factor: 2.299

Review 9.  Hepatitis C in pregnancy.

Authors:  C M Hunt; K L Carson; A I Sharara
Journal:  Obstet Gynecol       Date:  1997-05       Impact factor: 7.661

10.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

View more
  6 in total

Review 1.  Vertical hepatitis C virus transmission: Main questions and answers.

Authors:  Grazia Tosone; Alberto Enrico Maraolo; Silvia Mascolo; Giulia Palmiero; Orsola Tambaro; Raffaele Orlando
Journal:  World J Hepatol       Date:  2014-08-27

Review 2.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 3.  Treatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing Countries.

Authors:  Sina Aziz
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

Review 4.  Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.

Authors:  Manale Harfouche; Hiam Chemaitelly; Silva P Kouyoumjian; Sarwat Mahmud; Karima Chaabna; Zaina Al-Kanaani; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

5.  Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV.

Authors:  Ambreen Khokhar; Samina Noorali; Muhammad Sheraz; Kuha Mahalingham; Donald G Pace; Mohammad R Khanani; Omar Bagasra
Journal:  Libyan J Med       Date:  2012-12-31       Impact factor: 1.657

6.  The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses.

Authors:  Zaina Al Kanaani; Sarwat Mahmud; Silva P Kouyoumjian; Laith J Abu-Raddad
Journal:  R Soc Open Sci       Date:  2018-04-11       Impact factor: 2.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.